Go Deep
cbdMD, Inc.
cbdMD, Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 25,181 | 1.6 | 0.49 | 0.27 | 34.09 |
| Oct 2026 | 25,191 | 1.5 | 0.49 | 0.27 | 33.72 |
| Oct 2026 | 25,212 | 1.5 | 0.47 | 0.27 | 33.01 |
| Oct 2026 | 25,108 | 1.7 | 0.53 | 0.27 | 36.72 |
| Oct 2026 | 25,131 | 1.6 | 0.52 | 0.27 | 35.84 |
| Oct 2026 | 25,147 | 1.6 | 0.51 | 0.27 | 35.19 |
cbdMD, Inc. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 5,553,738.0 | 5,640,059.0 | 5,016,904.0 | 4,720,770.0 |
| Net Profit | -1,127,202.0 | -797,978.0 | -283,131.0 | -679,968.0 |
| EPS | -0.1 | -0.1 | -0.0 | — |
cbdMD, Inc. Revenue & Profit: Last 4 Years
| Line Item | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 |
|---|---|---|---|---|
| Revenue | 19,190,468.0 | 19,482,167.0 | 24,155,362.0 | 35,403,224.0 |
| Net Profit | -2,040,902.0 | -3,700,126.0 | -22,938,209.0 | -70,083,693.0 |
| EPS | -1.1 | -14.3 | -106.6 | -446.4 |
cbdMD, Inc. Balance Sheet
| Line Item | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 |
|---|---|---|---|---|
| Total Assets | 10,419,950.0 | 10,581,457.0 | 16,195,283.0 | 40,791,909.0 |
| Total Liabilities | 3,193,843.0 | 8,618,040.0 | 7,163,999.0 | 9,367,478.0 |
| Total Equity | 7,226,107.0 | 1,963,417.0 | 9,031,284.0 | 31,424,431.0 |
Owes vs Owns
cbdMD, Inc. owed $0.38 for every $1 it owned in Jun 2026, up from $0.23 in Sep 2022.
| Period | Jun 2026 | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.38× | 0.31× | 0.81× | 0.44× | 0.23× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
cbdMD, Inc. Assets & Liabilities Breakdown (USD millions)
What it owns — Sep 2025
Cash & short-term investments 21.7%Receivables 10.0%Inventory 26.2%Fixed assets (tangible) 10.0%Intangible assets 20.4%Long-term investments 6.7%Other assets 5.0%
How it's funded — Sep 2025
Short-term debt 7.5%Payables 11.3%Other liabilities 11.9%Shareholders' equity 69.3%
| Line Item | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 2.3 | 2.5 | 1.8 | 7.7 |
| Receivables | 1.0 | 1.0 | 1.2 | 1.4 |
| Inventory | 2.7 | 2.4 | 4.1 | 4.3 |
| Fixed assets (tangible) | 1.0 | 0.6 | 4.2 | 5.5 |
| Intangible assets | 2.1 | 2.9 | 3.2 | 17.8 |
| Long-term investments | 0.7 | 0.7 | 0.7 | 1.4 |
| Other assets | 0.5 | 0.6 | 1.0 | 2.6 |
| Liabilities & equity | ||||
| Short-term debt | 0.8 | 1.2 | 0.0 | 0.0 |
| Long-term debt | 0.0 | 0.0 | 2.4 | 3.7 |
| Payables | 1.2 | 1.5 | 1.9 | 2.0 |
| Other liabilities | 1.2 | 5.9 | 2.9 | 3.6 |
| Shareholders' equity | 7.2 | 2.0 | 9.0 | 31.4 |
| Net tangible assets | 5.1 | -0.9 | 5.8 | 13.6 |
cbdMD, Inc. Cash Flow
| Line Item | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 |
|---|---|---|---|---|
| Operating Activities | -1,452,375.0 | -352,792.0 | -4,302,051.0 | -14,967,150.0 |
| Investing Activities | -184,172.0 | -290,015.0 | 702,451.0 | -688,680.0 |
| Financing Activities | 1,445,236.0 | 1,297,500.0 | -1,322,774.0 | -4,035,360.0 |